Skip to main content

Search form

  • Connect with Us
  • Login
Home
  • About
    • Research Focus
    • Study Primer
    • Clinical Centers
    • Data Coordinating Center
    • Funding
    • Committees
    • Announcements
  • Overview
  • Research
    • Gene Array Project
      • Introduction - Protocol
      • Introduction - Brain Sampling
      • Introduction - Description of Core Laboratory
      • Gene Array Subjects
      • Starting Weights
      • Preliminary RNA Quality
      • Gene Array Quality Control - Explanation
      • Quality Control - White Matter
      • Quality Control - Frontal Cortex
      • Quality Control - Basal Ganglia
    • Bibliography
      • Authors
      • Keywords
  • Requests
  • FAQ
  • Query Tool
  • CHARTER Study
Home /Research /Bibliography

Bibliography

Found 4 results
Filters: Author is Croteau, David  [Clear All Filters]
2016
Ma Q, Vaida F, Wong J, Sanders CA, Kao Y-ting, Croteau D, Clifford DB, Collier AC, Gelman BB, Marra CM, et al. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol. 2016 ;22(2):170-8.
2012
Croteau D, Best BM, Letendre S, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JAllen, et al. Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration. AIDS. 2012 ;26(7):890-3.
Croteau D, Letendre S, Best BM, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, et al. Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrob Agents Chemother. 2012 ;56(4):1985-9.
2010
Croteau D, Letendre S, Best BM, Ellis RJ, Breidinger S, Clifford D, Collier A, Gelman B, Marra C, Mbeo G, et al. Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1. Antimicrob Agents Chemother. 2010 ;54(12):5156-60.
Sponsored by a U24 grant mechanism from the NIMH/NIH
U24MH100925